ethoxyresorufin has been researched along with Fatty Liver in 1 studies
ethoxyresorufin: structure
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Lipid deposition in livers of patients with the metabolic syndrome may necessitate dosage adjustments for toxic drugs, including CLZ." | 1.34 | Impaired microsomal oxidation of the atypical antipsychotic agent clozapine in hepatic steatosis. ( Murray, M; Ramzan, I; Zhang, WV, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, WV | 1 |
| Ramzan, I | 1 |
| Murray, M | 1 |
1 other study available for ethoxyresorufin and Fatty Liver
| Article | Year |
|---|---|
Impaired microsomal oxidation of the atypical antipsychotic agent clozapine in hepatic steatosis.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Clozapine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2E1; | 2007 |